Xinafoate salt of N4-[(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-N2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine
Details for Australian Patent Application No. 2008294473 (hide)
International Classifications
Event Publications
11 March 2010 PCT application entered the National Phase
PCT publication WO2009/031011 Priority application(s): WO2009/031011
8 April 2010 Amendment Made
The nature of the amendment is: Amend the invention title to read Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one) - 6-yl]-5-fluoro-N2-[3-methylaminocar-bonylmethyleneoxy)phenyl]-2,4-pyr imidinediamine
14 July 2011 Assignment before Grant
Pfizer Limited The application has been assigned to Rigel Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008294478-An energy generating system using a plurality of waterwheels
2008294472-Fastening tool for fastening different length elements
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser